TY - JOUR T1 - SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice JF - BMJ Open Gastroenterology JO - BMJ Open Gastro DO - 10.1136/bmjgast-2020-000381 VL - 7 IS - 1 SP - e000381 AU - Chih-Wei Liu AU - Chia-Chang Huang AU - Chien-Fu Hsu AU - Tzu-Hao Li AU - Yu-Lien Tsai AU - Ming-Wei Lin AU - Hung-Cheng Tsai AU - Shiang-Fen Huang AU - Ying-Ying Yang AU - Yun-Cheng Hsieh AU - Tzung-Yan Lee AU - Chang-Youh Tsai AU - Yi-Hsiang Huang AU - Ming-Chih Hou AU - Han-Chieh Lin Y1 - 2020/05/01 UR - http://bmjopengastro.bmj.com//content/7/1/e000381.abstract N2 - Background In non-alcoholic steatohepatitis (NASH), muscle wasting was an aggravating factor for the progression of hepatic steatosis. This study explores the potential benefits of chronic treatment with resveratrol, a strong activator of SIRT1 on the muscle wasting of NASH mice.Methods In vivo and in vitro study, we evaluate the SIRT1-dependent mechanisms and effects of resveratrol administration for 6 weeks with high-fat-methionine and choline deficient diet-induced NASH mice and palmitate-pretreated C2C12 myoblast cells.Results Resveratrol treatment improved grip strength and muscle mass of limbs, increased running distance and time on exercise wheels in NASH mice. There is a negative correlation between muscular SIRT1 activity and 3-nitrotyrosine levels of NASH and NASH-resv mice. The SIRT1-dependent effect of muscle wasting was associated with the suppression of oxidative stress, upregulation of antioxidants, inhibition of protein degradation, activation of autophagy, suppression of apoptotic activity, upregulation of lipolytic genes and the reduction of fatty infiltration in limb muscles of NASH mice. In vitro, resveratrol alleviated palmitate acid-induced oxidative stress, lipid deposition, autophagy dysfunction, apoptotic signals, and subsequently reduced fusion index and myotube formation of C2C12 cells. The beneficial effects of resveratrol were abolished by EX527.Conclusions Our study suggests that chronic resveratrol treatment is a potential strategy for amelioration of hepatic steatosis and muscle wasting in NASH mouse model. ER -